European Heart Journal Advance Access published online on April 11, 2007
European Heart Journal, doi:10.1093/eurheartj/ehm037
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology
1 Laboratory of Physiology, VU University Medical Center, Van der Boechorststraat, 7, 1081 BT, Amsterdam, The Netherlands
2 Charité Universitätskliniken, Campus Benjamin Franklin, Berlin, Germany
3 Keele University, Stoke-on-Trent, UK
4 S.Orsola Hospital, Brescia, Italy
5 University of Erlangen, Germany
6 University of Leuven, Belgium
7 Universita degli Studi del Piemonte Orientale, Novara, Italy
8 Rikshospitalet, Oslo, Norway
9 Middelheim Ziekenhuis, Antwerp, Belgium
10 University of Porto, Portugal
11 Institute of Cardiology UDMHSC, Debrecen, Hungary
12 University Hospital Maastricht, The Netherlands
13 Georg-August-Universität, Göttingen, Germany
14 Stavanger University Hospital, Norway
15 University of Wales College of Medicine, Cardiff, UK
Received 28 November 2006; accepted 23 February 2007.
* Corresponding author. Tel: +31 20 4448110; fax: +31 20 4448255. E-mail address: wj.paulus{at}vumc.nl
Diastolic heart failure (DHF) currently accounts for more than 50% of all heart failure patients. DHF is also referred to as heart failure with normal left ventricular (LV) ejection fraction (HFNEF) to indicate that HFNEF could be a precursor of heart failure with reduced LVEF. Because of improved cardiac imaging and because of widespread clinical use of plasma levels of natriuretic peptides, diagnostic criteria for HFNEF needed to be updated. The diagnosis of HFNEF requires the following conditions to be satisfied: (i) signs or symptoms of heart failure; (ii) normal or mildly abnormal systolic LV function; (iii) evidence of diastolic LV dysfunction. Normal or mildly abnormal systolic LV function implies both an LVEF > 50% and an LV end-diastolic volume index (LVEDVI) <97 mL/m2. Diagnostic evidence of diastolic LV dysfunction can be obtained invasively (LV end-diastolic pressure >16 mmHg or mean pulmonary capillary wedge pressure >12 mmHg) or non-invasively by tissue Doppler (TD) (E/E' > 15). If TD yields an E/E' ratio suggestive of diastolic LV dysfunction (15 > E/E' > 8), additional non-invasive investigations are required for diagnostic evidence of diastolic LV dysfunction. These can consist of blood flow Doppler of mitral valve or pulmonary veins, echo measures of LV mass index or left atrial volume index, electrocardiographic evidence of atrial fibrillation, or plasma levels of natriuretic peptides. If plasma levels of natriuretic peptides are elevated, diagnostic evidence of diastolic LV dysfunction also requires additional non-invasive investigations such as TD, blood flow Doppler of mitral valve or pulmonary veins, echo measures of LV mass index or left atrial volume index, or electrocardiographic evidence of atrial fibrillation. A similar strategy with focus on a high negative predictive value of successive investigations is proposed for the exclusion of HFNEF in patients with breathlessness and no signs of congestion.
The updated strategies for the diagnosis and exclusion of HFNEF are useful not only for individual patient management but also for patient recruitment in future clinical trials exploring therapies for HFNEF.
Key Words: Heart failure • Diastole • Tissue doppler • Natriuretic peptides • Ejection fraction
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Guazzi, J. Myers, M. A. Peberdy, D. Bensimhon, P. Chase, and R. Arena Exercise oscillatory breathing in diastolic heart failure: prevalence and prognostic insights Eur. Heart J., October 4, 2008; (2008) ehn437v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Authors/Task Force Members, K. Dickstein, A. Cohen-Solal, G. Filippatos, J. J.V. McMurray, P. Ponikowski, P. A. Poole-Wilson, A. Stromberg, D. J. van Veldhuisen, D. Atar, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur. Heart J., October 1, 2008; 29(19): 2388 - 2442. [Full Text] [PDF]
|
|
|
|
 |
|
 G J King, R T Murphy, I Almuntaser, K Bennett, E Ho, and A S Brown Alterations in myocardial stiffness in elite athletes assessed by a new Doppler index Heart, October 1, 2008; 94(10): 1323 - 1325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. H. Marwick and M. Schwaiger The Future of Cardiovascular Imaging in the Diagnosis and Management of Heart Failure, Part 2: Clinical Applications Circ Cardiovasc Imaging, September 1, 2008; 1(2): 162 - 170. [Full Text] [PDF]
|
|
|
|
 |
|
 W. T. Emery, I. Jadavji, J. B. Choy, and R. A. Lawrance Investigating the European Society of Cardiology Diastology Guidelines in a practical scenario Eur J Echocardiogr, September 1, 2008; 9(5): 685 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Handoko and W. J. Paulus Polishing the diastolic dysfunction measurement stick Eur J Echocardiogr, September 1, 2008; 9(5): 575 - 577. [Full Text] [PDF]
|
|
|
|
|
|
A. A Voors and R. M de Jong Treating diastolic heart failure Heart, August 1, 2008; 94(8): 971 - 972. [Full Text] [PDF]
|
|
|
|
|
|
N R Van de Veire, J De Sutter, J J Bax, and J R T C Roelandt Technological advances in tissue Doppler imaging echocardiography Heart, August 1, 2008; 94(8): 1065 - 1074. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. H. Marwick and M. Schwaiger The Future of Cardiovascular Imaging in the Diagnosis and Management of Heart Failure, Part 1: Tasks and Tools Circ Cardiovasc Imaging, July 1, 2008; 1(1): 58 - 69. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Y-M. Wang, M. Wang, C. W-K. Lam, I. H-S. Chan, Y. Zhang, and J. E. Sanderson Left Ventricular Filling Pressure by Doppler Echocardiography in Patients With End-Stage Renal Disease Hypertension, July 1, 2008; 52(1): 107 - 114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L Ingle, J G F Cleland, and A L Clark Perception of symptoms is out of proportion to cardiac pathology in patients with "diastolic heart failure" Heart, June 1, 2008; 94(6): 748 - 753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wang, D. S. Khoury, Y. Yue, G. Torre-Amione, and S. F. Nagueh Preserved left ventricular twist and circumferential deformation, but depressed longitudinal and radial deformation in patients with diastolic heart failure Eur. Heart J., May 2, 2008; 29(10): 1283 - 1289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G W K Yip, M Wang, T Wang, S Chan, J W H Fung, L Yeung, T Yip, S-T Lau, C-P Lau, M-O Tang, et al. The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction Heart, May 1, 2008; 94(5): 573 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Pavlopoulos, J. Grapsa, E. Stefanadi, V. Kamperidis, E. Philippou, D. Dawson, and P. Nihoyannopoulos The evolution of diastolic dysfunction in the hypertensive disease Eur J Echocardiogr, April 29, 2008; (2008) jen145v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Chin and L. J. Rubin Pulmonary arterial hypertension. J. Am. Coll. Cardiol., April 22, 2008; 51(16): 1527 - 1538. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Westermann, M. Kasner, P. Steendijk, F. Spillmann, A. Riad, K. Weitmann, W. Hoffmann, W. Poller, M. Pauschinger, H.-P. Schultheiss, et al. Role of Left Ventricular Stiffness in Heart Failure With Normal Ejection Fraction Circulation, April 22, 2008; 117(16): 2051 - 2060. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nozohoor, J. Nilsson, C. Luhrs, A. Roijer, and J. Sjogren Influence of Prosthesis-Patient Mismatch on Diastolic Heart Failure After Aortic Valve Replacement Ann. Thorac. Surg., April 1, 2008; 85(4): 1310 - 1317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Konduracka, A. Gackowski, P. Rostoff, D. Galicka-Latala, W. Frasik, and W. Piwowarska Diabetic cardiomyopathy: a controversial entity: reply Eur. Heart J., February 2, 2008; 29(4): 565 - 565. [Full Text] [PDF]
|
|
|
|
|
|
O. W. Nielsen, L. Kober, and C. Torp-Pedersen Heart failure with preserved ejection fraction: dangerous, elusive, and difficult Eur. Heart J., February 1, 2008; 29(3): 285 - 287. [Full Text] [PDF]
|
|
|
|
|
|
L. van Heerebeek, N. Hamdani, M. L. Handoko, I. Falcao-Pires, R. J. Musters, K. Kupreishvili, A. J.J. Ijsselmuiden, C. G. Schalkwijk, J. G.F. Bronzwaer, M. Diamant, et al. Diastolic Stiffness of the Failing Diabetic Heart: Importance of Fibrosis, Advanced Glycation End Products, and Myocyte Resting Tension Circulation, January 1, 2008; 117(1): 43 - 51. [Abstract] [Full Text] [PDF]
|
|